An overview on the use of antivirals for the treatment of patients with COVID19 disease
Author:
Affiliation:
1. Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA
2. Department of Pharmacy Services, Yale New Haven Health, New Haven, CT, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1847270
Reference127 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
2. Race to find COVID-19 treatments accelerates
3. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
4. Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implementation of analytical quality by design concepts for the optimization of quantitative 1H nuclear magnetic resonance (1H-qNMR) method for quantitation of novel anti-covid drugs (molnupiravir and favipiravir) in their pharmaceutical dosage forms;Microchemical Journal;2024-01
2. Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2: A Review;Current Pharmaceutical Biotechnology;2023-11
3. The COVID-19 pandemic’s effects on SMEs and travel agencies: The critical role of corporate social responsibility;Economic Analysis and Policy;2022-12
4. Unlocking the Mysteries of the Human Microbiome to Combat COVID-19;Human Microbiome;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3